thalidomide has been researched along with Actinic Reticuloid Syndrome in 21 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Actinic prurigo patients were analyzed before and after thalidomide treatment." | 7.72 | Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo. ( Cortés-Franco, R; Domínguez-Soto, L; Estrada-G, I; Estrada-Parra, S; Flores-Romo, L; Garibay-Escobar, A; Hojyo-Tomoka, T; Núñez-Vázquez, A; Pérez-Uribe, A; Santos-Argumedo, L; Vega-Memije, E, 2004) |
| "Treatment with thalidomide led to resolution of the disease." | 5.33 | Successful thalidomide therapy for actinic prurigo in a European woman. ( Hofer, A; Holzer, A; Kerl, H; Legat, FJ; Wolf, P, 2006) |
| "Thalidomide (100 mg/day) was commenced at the age of 11 years after an unsuccessful trial of other treatments and his lesions resolved within 2 months." | 5.31 | Long-term thalidomide for actinic prurigo. ( Muir, JB; Yong-Gee, SA, 2001) |
| "Actinic prurigo patients were analyzed before and after thalidomide treatment." | 3.72 | Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo. ( Cortés-Franco, R; Domínguez-Soto, L; Estrada-G, I; Estrada-Parra, S; Flores-Romo, L; Garibay-Escobar, A; Hojyo-Tomoka, T; Núñez-Vázquez, A; Pérez-Uribe, A; Santos-Argumedo, L; Vega-Memije, E, 2004) |
| "Based on present publications we review indications of the therapy of dermatoses with thalidomide as well as possible mechanisms of action and side effects of this drug." | 3.66 | [Thalidomide in dermatology]. ( Hunziker, T; Krebs, A, 1983) |
| "Treatment with thalidomide led to resolution of the disease." | 1.33 | Successful thalidomide therapy for actinic prurigo in a European woman. ( Hofer, A; Holzer, A; Kerl, H; Legat, FJ; Wolf, P, 2006) |
| "Actinic prurigo is a specific familial photodermatosis of uncertain pathogenesis." | 1.31 | Effectors of inflammation in actinic prurigo. ( Arrese, JE; Cortés-Franco, R; Dominguez-Soto, L; Guevara, E; Hojyo-Tomoka, MT; Piérard, GE; Vega-Memije, E, 2001) |
| "Thalidomide (100 mg/day) was commenced at the age of 11 years after an unsuccessful trial of other treatments and his lesions resolved within 2 months." | 1.31 | Long-term thalidomide for actinic prurigo. ( Muir, JB; Yong-Gee, SA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Watts-Santos, A | 1 |
| Martinez-Rico, JC | 1 |
| Gomez-Flores, M | 1 |
| Ocampo-Candiani, J | 1 |
| Alba-Rojas, E | 1 |
| Kaushik, A | 1 |
| Narang, T | 1 |
| Handa, S | 1 |
| Lahouel, M | 1 |
| Ben Kahla, M | 1 |
| Aounallah, A | 1 |
| Mokni, S | 1 |
| Sriha, B | 1 |
| Belajouza, C | 1 |
| Denguezli, M | 1 |
| Pita da Veiga, G | 1 |
| Pérez-Feal, P | 1 |
| Peña-López, S | 1 |
| Fernández-Redondo, V | 1 |
| Rodríguez-Granados, MT | 1 |
| Pérez-Paredes, MG | 1 |
| Rodríguez-Prieto, MÁ | 1 |
| Ruiz-González, I | 1 |
| Valladares-Narganes, LM | 1 |
| Gozali, MV | 1 |
| Zhou, BR | 1 |
| Luo, D | 1 |
| Vega-Memije, ME | 2 |
| Mosqueda-Taylor, A | 1 |
| Irigoyen-Camacho, ME | 1 |
| Hojyo-Tomoka, MT | 3 |
| Domínguez-Soto, L | 4 |
| Cortes-Franco, R | 3 |
| Estrada-G, I | 1 |
| Garibay-Escobar, A | 1 |
| Núñez-Vázquez, A | 1 |
| Hojyo-Tomoka, T | 1 |
| Vega-Memije, E | 2 |
| Pérez-Uribe, A | 1 |
| Flores-Romo, L | 1 |
| Santos-Argumedo, L | 1 |
| Estrada-Parra, S | 1 |
| Safa, G | 1 |
| Piéto-Le Corvaisier, C | 1 |
| Hervagault, B | 1 |
| Holzer, A | 1 |
| Wolf, P | 1 |
| Legat, FJ | 1 |
| Kerl, H | 1 |
| Hofer, A | 1 |
| Belaube, P | 1 |
| Garcin, G | 1 |
| Marchand, JP | 1 |
| Privat, Y | 1 |
| Hunziker, T | 1 |
| Krebs, A | 1 |
| Berger, TG | 1 |
| Hoffman, C | 1 |
| Thieberg, MD | 1 |
| Judge, MR | 1 |
| Kobza-Black, A | 1 |
| Hawk, JL | 2 |
| Grabczyska, SA | 1 |
| Arrese, JE | 1 |
| Guevara, E | 1 |
| Piérard, GE | 1 |
| Yong-Gee, SA | 1 |
| Muir, JB | 1 |
| Calnan, CD | 1 |
| Meara, RH | 1 |
| Saul, A | 1 |
| Flores, O | 1 |
| Novales, J | 1 |
| Peyron, JL | 1 |
| Meynadier, J | 1 |
4 reviews available for thalidomide and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Update on treatment of photodermatosis.
Topics: Antimalarials; Antioxidants; beta Carotene; Calcineurin Inhibitors; Glucocorticoids; Histamine Antag | 2016 |
Diagnosis and treatment of actinic prurigo.
Topics: Dermatologic Agents; Diagnosis, Differential; Humans; Photosensitivity Disorders; Prurigo; Thalidomi | 2003 |
Managing PLE and actinic prurigo.
Topics: Acute Disease; Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Photosensitivity Disorder | 1997 |
The pharmacological basis for the treatment of photodermatoses.
Topics: Antigens; Antimalarials; beta Carotene; Carotenoids; DNA; Female; Humans; Immunosuppression Therapy; | 1986 |
17 other studies available for thalidomide and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Thalidomide: An option for the pediatric patient with actinic prurigo.
Topics: Age Factors; Child; Female; Humans; Immunosuppressive Agents; Photosensitivity Disorders; Skin Disea | 2020 |
Successful use of apremilast as a steroid-sparing agent in chronic actinic dermatitis.
Topics: Chronic Disease; Humans; Photosensitivity Disorders; Steroids; Thalidomide | 2020 |
Severe chronic actinic dermatitis treated successfully with Thalidomide.
Topics: Chronic Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Photosensitivity Disorders; Th | 2020 |
Apremilast-induced photosensitivity confirmed by photobiological study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Male; Middle Aged; Photosensitivity Disorders; Thal | 2021 |
Lenalidomide-induced photosensitivity.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Humans; Lenalidomide; Male; Photosensitivity Disorders; | 2013 |
Actinic prurigo cheilitis: clinicopathologic analysis and therapeutic results in 116 cases.
Topics: Administration, Topical; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Inflamma | 2002 |
Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo.
Topics: Adolescent; Adult; CD3 Complex; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interfe | 2004 |
Recalcitrant chronic actinic dermatitis treated with low-dose thalidomide.
Topics: Adult; Eczema; Humans; Male; Photosensitivity Disorders; Thalidomide | 2005 |
Successful thalidomide therapy for actinic prurigo in a European woman.
Topics: Adult; Europe; Female; Humans; Photosensitivity Disorders; Prurigo; Thalidomide; Treatment Outcome | 2006 |
[Should thalidomide be rehabilitated?].
Topics: Chemical Phenomena; Chemistry; Humans; Leprosy; Photosensitivity Disorders; Thalidomide | 1983 |
[Thalidomide in dermatology].
Topics: Animals; Female; Guinea Pigs; Humans; Immunity; Leprosy; Lupus Erythematosus, Discoid; Male; Mice; N | 1983 |
Prurigo nodularis and photosensitivity in AIDS: treatment with thalidomide.
Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Male; Middle Aged; Photosensitivity Diso | 1995 |
Guidelines for the clinical use and dispensing of thalidomide.
Topics: Adolescent; Adult; Aged; Child; Clinical Protocols; Female; Humans; Male; Middle Aged; Photosensitiv | 1995 |
Effectors of inflammation in actinic prurigo.
Topics: Adolescent; Adult; Child; Female; Genetic Predisposition to Disease; Humans; Immunohistochemistry; I | 2001 |
Long-term thalidomide for actinic prurigo.
Topics: Adult; HLA-DR4 Antigen; Humans; Immunosuppressive Agents; Male; Photosensitivity Disorders; Prurigo; | 2001 |
Actinic prurigo (Hutchinson's summer prurigo).
Topics: Adult; Diagnosis, Differential; Female; Humans; Male; Photosensitivity Disorders; Prurigo; Seasons; | 1977 |
Polymorphous light eruption: Treatment with thalidomide.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Photosensitiv | 1976 |